Ibrutinib versus temsirolimus: 3-year follow-up of patients with previously treated mantle cell lymphoma from the phase 3, international, randomized, open-label RAY study

full text is not available in portal

Category:: Magazine publication
Type:: Magazine publication
Published in:: LEUKEMIA no. 32, edition 8, pages 1799 - 1803,
ISSN: 0887-6924
ISSN:: 0887-6924
Publication year:: 2018
DOI:: Digital Object Identifier (open in new tab) 10.1038/s41375-018-0023-2
Verified by:: No verification

seen 110 times

Search